Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey N Lee

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Molecular Therapy. Oncology|May 25, 2026
Natural killer cell immunotherapy for pancreatic cancer: Release the brakesStacey N Lee, Jeanette E Boudreau
Journal for Immunotherapy of Cancer|February 24, 2026
Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibitionStacey N Lee, Riley J Arseneau, Thomas Arnason, et al.
Frontiers in Immunology|December 13, 2023
Killer instincts: natural killer cells as multifactorial cancer immunotherapySarah Nersesian, Emily B Carter, Stacey N Lee, et al.
Journal of Leukocyte Biology|March 9, 2026
Adenosine drives suppression of CD16low NK cell responses against HGSC via NKG2A:HLA-E interactionsAnna P Nicolela, Sarah Nersesian, Stacey N Lee, et al.
Translational Oncology|November 13, 2020
NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysisSarah Nersesian, Sarah L Schwartz, Stephanie R Grantham, et al.
Frontiers in Immunology|December 29, 2025
Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinomaRiley J Arseneau, Jorge P Mejia, Sarah Nersesian, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|October 23, 2023
BioCanRx Summit for Cancer Immunotherapy 2022 ProceedingsStacey N Lee, Victoria Hoskin, Céline M Laumont, et al.
Journal of Clinical Medicine|July 27, 2022
PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical PathologyRyan DeCoste, Yutaka Amemiya, Sarah Nersesian, et al.
Frontiers in Immunology|February 6, 2024
Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophagesSarah Nersesian, Riley J Arseneau, Jorge P Mejia, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer CareJessica L Nickerson, Chloe Cyr, Riley J Arseneau, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Molecular Therapy. Oncology|May 25, 2026
Natural killer cell immunotherapy for pancreatic cancer: Release the brakesStacey N Lee, Jeanette E Boudreau
Journal for Immunotherapy of Cancer|February 24, 2026
Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibitionStacey N Lee, Riley J Arseneau, Thomas Arnason, et al.
Frontiers in Immunology|December 13, 2023
Killer instincts: natural killer cells as multifactorial cancer immunotherapySarah Nersesian, Emily B Carter, Stacey N Lee, et al.
Journal of Leukocyte Biology|March 9, 2026
Adenosine drives suppression of CD16low NK cell responses against HGSC via NKG2A:HLA-E interactionsAnna P Nicolela, Sarah Nersesian, Stacey N Lee, et al.
Translational Oncology|November 13, 2020
NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysisSarah Nersesian, Sarah L Schwartz, Stephanie R Grantham, et al.
Frontiers in Immunology|December 29, 2025
Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinomaRiley J Arseneau, Jorge P Mejia, Sarah Nersesian, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|October 23, 2023
BioCanRx Summit for Cancer Immunotherapy 2022 ProceedingsStacey N Lee, Victoria Hoskin, Céline M Laumont, et al.
Journal of Clinical Medicine|July 27, 2022
PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical PathologyRyan DeCoste, Yutaka Amemiya, Sarah Nersesian, et al.
Frontiers in Immunology|February 6, 2024
Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophagesSarah Nersesian, Riley J Arseneau, Jorge P Mejia, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer CareJessica L Nickerson, Chloe Cyr, Riley J Arseneau, et al.
Pageof 2